Jack Wallace
Stock Analyst at Guggenheim
(2.38)
# 1,383
Out of 4,479 analysts
22
Total ratings
58.33%
Success rate
-3.44%
Average return
Main Sectors:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCM R1 RCM | Maintains: Buy | $17 → $15 | $10.90 | +37.61% | 4 | Apr 5, 2024 | |
| WW WW International | Reiterates: Buy | $12 | $1.13 | +966.67% | 2 | Mar 18, 2024 | |
| HIMS Hims & Hers Health | Maintains: Buy | $15 → $17 | $21.21 | -19.85% | 4 | Feb 27, 2024 | |
| HCAT Health Catalyst | Upgrades: Buy | $14 | $6.10 | +129.51% | 3 | Jan 26, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $253 → $220 | $207.47 | +6.04% | 1 | Nov 3, 2023 | |
| VEEV Veeva Systems | Upgrades: Buy | $226 | $182.85 | +23.60% | 2 | Jun 1, 2023 | |
| PHR Phreesia | Maintains: Buy | $35 → $40 | $20.50 | +95.12% | 4 | Mar 29, 2023 | |
| AMWL American Well | Reiterates: Buy | $5 | $0.30 | +1,594.92% | 1 | Mar 15, 2023 | |
| PINC Premier | Initiates: Neutral | n/a | $18.50 | - | 1 | Apr 14, 2022 |
R1 RCM
Apr 5, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $10.90
Upside: +37.61%
WW International
Mar 18, 2024
Reiterates: Buy
Price Target: $12
Current: $1.13
Upside: +966.67%
Hims & Hers Health
Feb 27, 2024
Maintains: Buy
Price Target: $15 → $17
Current: $21.21
Upside: -19.85%
Health Catalyst
Jan 26, 2024
Upgrades: Buy
Price Target: $14
Current: $6.10
Upside: +129.51%
IQVIA Holdings
Nov 3, 2023
Maintains: Buy
Price Target: $253 → $220
Current: $207.47
Upside: +6.04%
Veeva Systems
Jun 1, 2023
Upgrades: Buy
Price Target: $226
Current: $182.85
Upside: +23.60%
Phreesia
Mar 29, 2023
Maintains: Buy
Price Target: $35 → $40
Current: $20.50
Upside: +95.12%
American Well
Mar 15, 2023
Reiterates: Buy
Price Target: $5
Current: $0.30
Upside: +1,594.92%
Premier
Apr 14, 2022
Initiates: Neutral
Price Target: n/a
Current: $18.50
Upside: -